Liver Transplantation for Non-Hepatocellular Carcinoma Malignancies

被引：6
|
作者：
Gores, Gregory J. [1 ]
Heimbach, Julie K. [1 ]
Rosen, Charles B. [1 ]
机构：
[1] Mayo Clin, Coll Med, William Von Liebig Transplant Ctr, Rochester, MN 55905 USA
来源：
LIVER TRANSPLANTATION | 2010年 / 16卷
关键词：
HEPATIC EPITHELIOID HEMANGIOENDOTHELIOMA; CHOLANGIOCARCINOMA; EXPERIENCE; SURVIVAL; TUMORS;
D O I：
10.1002/lt.22145
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Key Points 1. Hepatic epithelioid hemangioendothelioma is a rare disease with a variable natural history; current data support liver transplantation for unresectable disease. 2. Anti-vascular endothelial cell growth factor therapy may change the approach to hepatic epithelioid hemangioendothelioma in the future. 3. The role of liver transplantation in the treatment of neuroendocrine tumors remains unclear; more data obtained by standardized approaches are needed for evidence-based decision making. 4. Liver transplantation is curative in highly selected patients with perihilar cholangiocarcinoma when it is combined with neoadjuvant therapy. Liver Transpl 16:S22-S25, 2010. copy; 2009 AASLD. Copyright © 2009 American Association for the Study of Liver Diseases.
引用
收藏
页码：S22 / S25
页数：4
相关论文
共 50 条
  • [1] NON-HEPATOCELLULAR CARCINOMA LIVER MALIGNANCIES IN VETERANS WITH HEPATITIS C
    Jones, J. L.
    Waters, B.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2012, 60 (01) : 405 - 405
  • [2] Liver Transplantation for Non-hepatocellular Carcinoma Malignancy: A Single-Center Experience
    Mont Alverne Pierre, Alessandra Maria
    Veras, Camila Monteiro
    Esmeraldo, Ticiana Mota
    Schwermann, Maximilian Pinho
    Studart e Neves, Marina Seixas
    Bastos Pinho, Jose Eudes
    Canito Brasil, Ivelise Regina
    TRANSPLANTATION PROCEEDINGS, 2019, 51 (10) : 3355 - 3359
  • [3] Liver Transplantation for Non-Hepatocellular Carcinoma Malignancy: Indications, Limitations, and Analysis of the Current Literature
    Grossman, Eric J.
    Millis, J. Michael
    LIVER TRANSPLANTATION, 2010, 16 (08) : 930 - 942
  • [4] Donor Factors Similarly Impact Survival Outcome After Liver Transplantation in Hepatocellular Carcinoma and Non-hepatocellular Carcinoma Patients
    Salgia, Reena J.
    Goodrich, Nathan P.
    Marrero, Jorge A.
    Volk, Michael L.
    DIGESTIVE DISEASES AND SCIENCES, 2014, 59 (01) : 214 - 219
  • [5] Donor Factors Similarly Impact Survival Outcome After Liver Transplantation in Hepatocellular Carcinoma and Non-hepatocellular Carcinoma Patients
    Reena J. Salgia
    Nathan P. Goodrich
    Jorge A. Marrero
    Michael L. Volk
    Digestive Diseases and Sciences, 2014, 59 : 214 - 219
  • [6] CEUS LI-RADS Categories to Distinguish Hepatocellular Carcinoma and Non-Hepatocellular Carcinoma Malignancies Response
    Zheng, Wei
    Zhou, Jian-hua
    RADIOLOGY, 2020, 296 (02) : E121 - E122
  • [7] Non-hepatocellular carcinoma spinal metastases
    Goodwin, C. Rory
    Abu-Bonsrah, Nancy
    Boone, Christine
    Ruiz-Valls, Alejandro
    Sankey, Eric W.
    Sarabia-Estrada, Rachel
    Elder, Benjamin D.
    Kosztowski, Thomas
    Sciubba, Daniel M.
    JOURNAL OF CLINICAL NEUROSCIENCE, 2016, 27 : 22 - 27
  • [8] Risk of primary non-hepatocellular malignancies in hereditary hemochromatosis
    Geier, D
    Hebert, B
    Potti, A
    ANTICANCER RESEARCH, 2002, 22 (6B) : 3797 - 3799
  • [9] Liver transplantation for unresectable malignancies: Beyond hepatocellular carcinoma
    Amer, A.
    Wilson, C. H.
    Manas, D. M.
    EJSO, 2019, 45 (12): : 2268 - 2278
  • [10] LIVER TRANSPLANTATION FOR UNRESECTABLE MALIGNANCIES: BEYOND HEPATOCELLULAR CARCINOMA
    Amer, Aimen
    Wilson, Colin
    Manas, Derek
    TRANSPLANT INTERNATIONAL, 2019, 32 : 227 - 227
12345